UNSPSC 51401562: Chlordiazepoxide lactam

This classification denotes a benzodiazepine with the molecular formula C15H11ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8X1XP5M0SB, chemically known as 5-phenyl-7-chloro-3h-1,4-benzodiazepin-2(1h)-one 4-oxide, but more generally known as chlordiazepoxide lactam, which bears US NIH Compound Identifier 13756. European Medicines Agency schedules chlordiazepoxide lactam or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06179MIG.

Most nations, for tariff purposes, schedule chlordiazepoxide lactam under HS 29339110. SMILES: C1CCC(CC1)C2=[N+](CC(=O)NC3C2CC(CC3)CL)[O-].

UNSPSC 51401562 Chlordiazepoxide lactam, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal pharmaceutical scope. The single identified recent opportunity — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 — solicits naloxone and drug deactivation systems rather than chlordiazepoxide lactam itself, indicating a mismatch between the code assignment and the actual goods being procured. The Seminole County solicitation targets community health initiatives and requires 1,900 units of naloxone and 800 safe drug deactivation systems annually on a competitive bid basis with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs in their proposals, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The initial contract term runs two years with an optional one-year renewal, and the procurement is potentially funded through FEMA, introducing federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act.

Activity under this code remains sparse and geographically limited. Seminole County represents the only recent issuing body identified, and the mismatch between the code's nominal scope and the naloxone procurement suggests either miscoding or minimal current demand for chlordiazepoxide lactam through state and local channels. The Seminole County IFB response deadline was July 26, 2023, and the procurement does not specify explicit set-asides for disadvantaged enterprises, though standard requirements for U.S. work authorization and insurance coverage apply. Business development professionals should verify whether this code continues to attract pharmaceutical procurement activity in their target markets or whether opportunities under this designation remain infrequent.